Neuro-Bio has been mentioned as Global Alzheimer’s Disease Diagnostic Market Key Player by Maximize market research pvt. ltd. To read the full article, click the link.
Neuro-Bio was mentioned on 2 articles on August the 27th on Mergermarket, an ACURIS company. Please find here the full article on Neuro-Bio’s fundraising plans: Neuro-Bio seeks to raise GBP 10m Series C by 1H22 for Alzheimer’s peptide drug – CEO _ Mergermarket And...
Neuro-Bio is proud to be mentioned in the Compromiso Empresial. See below for the translated version: Spain: a point of interest for international social start-ups Programs such as Rising UP in Spain are betting on attracting young innovative technology companies from...
NEURO-BIO LTD HAS BEEN GRANTED A TECNIOSPRING INDUSTRY AWARD 2021 Neuro-Bio has been awarded a Tecniospring INDUSTRY award together with the Catalan CRO, Xenopat (www.xenopat.com ) to develop a new antitumor drug and / or antimetastatic drug based on the inhibition of...
January 2020, all of Neuro-Bio are receiving training in the latest ISO standards for Quality Management and Medical Device R&D. This training and the subsequent accreditation in ISO9001/13485 will enable the company to continue to progress with it’s biomarker...
